|
CCDC115 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20359999999931E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31039999995419E-06 |
| Normal-vs-Stage2 |
3.564800E-03 |
| Normal-vs-Stage3 |
1.217740E-04 |
| Normal-vs-Stage4 |
4.62160000003209E-06 |
| Stage1-vs-Stage2 |
6.259400E-01 |
| Stage1-vs-Stage3 |
7.157000E-01 |
| Stage1-vs-Stage4 |
5.677400E-01 |
| Stage2-vs-Stage3 |
8.498800E-01 |
| Stage2-vs-Stage4 |
4.619000E-01 |
| Stage3-vs-Stage4 |
4.449000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.42110000007123E-07 |
| Normal-vs-AfricanAmerican |
1.717760E-01 |
| Normal-vs-Asian |
4.85559999996443E-06 |
| Caucasian-vs-AfricanAmerican |
7.603900E-02 |
| Caucasian-vs-Asian |
6.553000E-01 |
| AfricanAmerican-vs-Asian |
1.055820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.63890000000255E-05 |
| Normal-vs-Female |
1.88420000002409E-06 |
| Male-vs-Female |
6.668200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.86059999974076E-07 |
| Normal-vs-Age(41-60Yrs) |
2.34339999999333E-05 |
| Normal-vs-Age(61-80Yrs) |
1.162790E-03 |
| Normal-vs-Age(81-100Yrs) |
3.727700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.587400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.162400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.577200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.213400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.564600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.819400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.319000E-01 |
| Classical-VS-Follicular |
7.645400E-01 |
| Classical-VS-Other |
5.404400E-01 |
| Classical-VS-Normal |
5.65490000048463E-07 |
| Tall-VS-Follicular |
8.761400E-01 |
| Tall-VS-Other |
4.758800E-01 |
| Tall-VS-Normal |
8.118300E-03 |
| Follicular-VS-Other |
6.245800E-01 |
| Follicular-VS-Normal |
1.844330E-03 |
| Other-VS-Normal |
2.366300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37279999999451E-05 |
| Normal-vs-N1 |
9.10200026460473E-10 |
| N0-vs-N1 |
2.461100E-03 |
|
|
